Chronic hepatitis B treats the emergence expected to lower hepatocarcinoma or liver cirrhosis of the tactics
From Chinese Medical Association hepatopathy credit will, sponsor jointly at Chinese liver disease magazine editorial board " Clinical academic conference and Europe hepatopathy learn national the intersection of liver and disease on the seventh on day " Held a few days ago. It is reported focus of meeting this topic one of to explore chronic hepatitis B treat the intersection of country and " the eleven 5 " of tactics optimally The special subject of great science and technology is studied. In addition, the conference has also released an item of newest data, reveal the chronic hepatitis B patient accepting in order to treat more definitely than the, add up to the intersection of e and the intersection of antigen and serological conversion ratio four year ' Namely three big male genital transfer to three little male genital) Up to 66%.
Know Vice Chairman Professor Ren Hong's introduction according to credit of hepatopathy of this Chinese Medical Association, President of conference, this country " Eleven five " The result of subject for research will further optimize existing chronic hepatitis B and treat the tactics, improve a patient and treat curative effect. It is reported, at present, virus hepatitis patients such as hepatitis B, the third liver of countries all over the world,etc. are close to 500 million, accounts for 1/12 of global population. China the intersection of hepatitis B and the intersection of virus and the intersection of number of the infected and largest country, almost, die of the intersection of hepatitis B and relevant disease by 300,000 people each time, such as liver cirrhosis, hepatocarcinoma.
It is introduced, Professor Ren Hong's responsible research object, enter 4000 slow hepatitis B patients of group together, it is the longest to follow up a case by regular visits to but nearly 8 is annual.
|
0 comments:
Post a Comment